Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nexus AG's Enterprise Value for the quarter that ended in Sep. 2025 was €1,124.6 Mil.
Nexus AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €46.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexus AG EV-to-EBIT Related Terms
Nexus AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Nexus AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0FGL vs VEEV, GEHC, TEM: EV-to-EBIT Comparison
For the Health Information Services subindustry, Nexus AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexus AG EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nexus AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nexus AG's EV-to-EBIT falls into.
Nexus AG's current Enterprise Value is €1,125.4 Mil.
Nexus AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €46.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexus AG (LTS:0FGL) has a EV-to-EBIT of 24.26 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nexus AG and its competitors. This is 13% below median its historical median of 28.02. Over the past decade, Nexus AG's EV-to-EBIT has ranged from 18.36 to 56.19.
Is Nexus AG's EV-to-EBIT too high?
Nexus AG's current EV-to-EBIT of 24.26 is 13% below median its 10-year median of 28.02. Over the past 10 years, this metric has ranged from a low of 18.36 to a high of 56.19. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Nexus AG's value of 24.26 is 54.1% above this industry median. Overall, Nexus AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Nexus AG's EV-to-EBIT compare to VEEV and GEHC?
Nexus AG's EV-to-EBIT of 24.26 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.74. Nexus AG's value of 24.26 is 54.1% above this benchmark. Historically, Nexus AG's own EV-to-EBIT has ranged from 18.36 to 56.19 over the past decade. While the company's 10-year median is 28.02 vs. the industry median of 15.74, Nexus AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexus AG's current EV-to-EBIT of 24.26 is 54.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nexus AG and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexus AG's current EV-to-EBIT is 24.26, which is 13% below median its own 10-year median of 28.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus AG stock overvalued right now?
Nexus AG (LTS:0FGL) has a current EV-to-EBIT of 24.26. The stock's GF Value™ is €74.59, compared to a current price of €71.70 — trading 3.9% below its estimated fair value. The current EV-to-EBIT is 24.26, which is 13% below median its 10-year median of 28.02 and 54.1% above the Healthcare Providers & Services industry median of 15.74. Nexus AG's overall GF Score™ is 11/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Nexus AG (LTS:0FGL), the current EV-to-EBIT is 24.26 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexus AG (LTS:0FGL) Overvalued in 2026?
Based on GuruFocus' analysis, Nexus AG stock appears to be undervalued.
The current stock price of €71.70 is trading 3.9% below its estimated GF Value™ of €74.59.
Key valuation signals for LTS:0FGL:
EV-to-EBIT: 24.26 (13% below median its 10-year median of 28.02)
GF Value™: €74.59 vs. price of €71.70 (3.9% below fair value)
Industry Position: 54.1% above the Healthcare Providers & Services median
No single metric tells the full story. See the LTS:0FGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, and IT services for IT operations especially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.
11GF Score
Get the complete analysis for LTS:0FGL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0FGL has been successfully added to your 
